ClinConnect ClinConnect Logo
Search / Trial NCT06314789

The Use of Lung Ultrasonography in the Delivery Room in Neonates

Launched by KIRIKKALE UNIVERSITY · Mar 11, 2024

Trial Information

Current as of November 14, 2025

Enrolling by invitation

Keywords

Newborn, Premature Infant, Lung Ultrasonography

ClinConnect Summary

This study is checking whether a lung ultrasound score, measured in the delivery room within the first 30 minutes after birth, can help predict which newborns might develop breathing problems. It is a single-group, diagnostic study (not testing a treatment). In addition to the initial score, researchers will reassess the ultrasound score at about 2, 6, and 24 hours after birth to see if changes over time better predict how severe any breathing issues could be or whether the baby will need extra help breathing in the hospital. Images are taken with a standard ultrasound probe and may be reviewed on a mobile device as part of the process.

Who can participate? Babies born at Kırıkkale University Faculty of Medicine Hospital who are at least 34 weeks gestation, had a delivery there, and whose parents or guardians give consent. Exclusions include babies born before 34 weeks, deliveries outside the hospital, lack of consent, or the presence of major lung, heart, or birth defects. The study plans to include about 112 newborns and is currently enrolling by invitation, with recruitment starting in March 2024 and estimated to finish around March 2025. There is no experimental treatment involved; this test is used to help doctors predict and plan for possible breathing problems.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients born in Kırıkkale University Faculty of Medicine Hospital who were over 34 weeks and who underwent lung ultrasonography from the delivery room
  • Patients who consented to the study
  • Exclusion Criteria:
  • Patients born under 34 weeks
  • Patients whose delivery did not take place at Kırıkkale University Medical Faculty Hospital
  • Patients without study consent
  • Patients with lung anomalies
  • Congenital heart disease
  • Those with major congenital anomalies

About Kırıkkale University

Kırıkkale University is a distinguished academic institution based in Turkey, recognized for its commitment to advancing medical research and education. The university actively engages in clinical trials aimed at enhancing healthcare outcomes and contributing to the scientific community. With a focus on innovation and collaboration, Kırıkkale University leverages its multidisciplinary expertise to conduct rigorous clinical studies that address pressing health challenges. Its research initiatives are guided by ethical standards and a dedication to improving patient care through evidence-based findings.

Locations

Kirikkale, Turkey

Patients applied

0 patients applied

Trial Officials

Umit Ayse Tandircioglu

Principal Investigator

Kırıkkale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported